Volume 28, Issue 1 (1-2014)                   Med J Islam Repub Iran 2014 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Farid Hosseini R, Jabbari Azad F, Yousefzadeh H, Rafatpanah H, Hafizi S, Tehrani H et al . Serum levels of vascular endothelial growth factor in chronic Obstructive pulmonary disease. Med J Islam Repub Iran 2014; 28 (1) :539-544
URL: http://mjiri.iums.ac.ir/article-1-2422-en.html
Mashhad University of Medical Sciences, Mashhad, Iran. , arc@mums.ac.ir
Abstract:   (3847 Views)

  Background :Chronic obstructive pulmonary disease (COPD) is a third leading cause of death.

  Methods : In this case control study, we prepared 5 cc bloods from the antecubital vein of 100 COPD patients and 40 healthy individuals as control group. Vascular endothelial growth factor (VEGF) expression protein level was measured by ELISA in both groups.

  Results : We found that concentration of VEGF in blood serum of patients with COPD (189.9±16pg/ml) was significantly higher than the control group (16.4±3.48pg/ml) (p<0.001). While VEGF serum level in emphysematous patients wasn’t significantly different with control group (p=0.07). Furthermore VEGF serum level in COPD patients was proportionally increased with severity of disease (p<0.001). Besides all COPD patients, regardless of their smoking status, were experienced significantly higher levels of VEGF than healthy ones (p=0.001 z=4.3).

  Conclusion : Our results suggest VEGF serum concentration as the sensitive index for severity and activity of COPD and its prognosis.

Full-Text [PDF 616 kb]   (1504 Downloads)    
Type of Study: Original Research | Subject: Pulmonary Disease

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.